Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
The CMS on Monday handed state governors significant power to overhaul their insurance exchanges and changed the way it will evaluate so-called innovation waivers.
Amazon has been in the headlines disrupting markets for years, but over the past few months, we have seen more and more news about the company’s ambitions in healthcare. From the alliance with JPMorgan Chase and Berkshire Hathaway that Dr. Atul Gawande has been appointed to lead to the purchase of PillPack, Amazon is clearly serious about healthcare. The question now is how far will Amazon, the master disrupter, take this?
President Trump wants to force drug companies to disclose their prices in TV ads — and that’s going to hit five companies much harder than any others: Pfizer, AbbVie, Eli Lilly, Amgen, and Allergan.
The confidential records of about 75,000 consumers have been hacked from one of the data portals used to help people get health plans through the Affordable Care Act’s federal insurance marketplace, the Trump administration announced on Friday.
Open enrollment is the specific time period each year when individuals can purchase health insurance for the upcoming year. And this year, it starts Monday, Oct. 15 and ends Jan. 15.
Roughly 140,000 Californians spend the equivalent of a part-time job — 12 to 20 hours a week — in a dialysis clinic, where a machine functioning as a kidney filters waste out of their blood.
Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress.
In this election season, lawmakers are taking on drug distributors with abandon, and many seem to relish the role.
Prescription drug advertisements on television will soon direct patients to more information about the cost of the drugs under new principles agreed to by members of the largest drug industry trade group.
U.S. health officials want to force pharmaceutical companies to disclose the prices of their products in television advertisements, setting up a clash with drugmakers who see the move as impinging free speech.